LUPS-Lipids and Glucose Under Prospective Surveillance

Asklepios proresearch1,962 enrolled

Overview

Prospective, non-randomized cohort study to analyse genetic variations, dietary patterns, perceived stress and anxiety and early changes in lipid metabolism leading to the metabolic syndrome and type 2 diabetes

The LUPS-study is a collaboration between Asklepios Clinics Hamburg GmbH and University Clinic Hamburg Eppendorf, Germany. This study is assessing a multitude of serum biomarkers, anthropometrics, dietary habits, physical activity, perceived stress along with genetic information from "healthy workers" (25-60years) to better understand phenotype-genotype associations leading to MetS and type 2 diabetes.

Study Type

OBSERVATIONAL

Enrollment

1,962

Conditions

Metabolic Syndrome Type 2 Diabetes

Eligibility

Sex: ALLMin age: 25 YearsMax age: 60 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * 25-60 years men and women willing to give consent Exclusion Criteria: * diabetes (type 1 or 2)

Locations (2)

Asklepios Klinik St.Georg

Hamburg, Germany

Universitätsklinikum Eppendorf

Hamburg, Germany

Outcomes

Primary Outcomes

Metabolic Syndrome, Type 2 Diabetes

assessing risk factors, e.g. HDL, BMI, Blood Pressure, FPG

Time frame: 10 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.